A Symposium on a new development of Proton Radiotherapy Nijmegen, September 17th, 2010 We want to contribute to optimal treatments for patients close to.

Slides:

Advertisements

Similar presentations

Gert-Jan Euverink, deputy-director research. First initiative in The Netherlands bridging the gap between: Bio- and separation technology Drinking water.

Advertisements

Information and Communication Technologies (ICT) in the Seventh Framework Programme Coordination actions ICT Calls Jan- March 2012.

INFSO/F3 1 The TEN-Telecom Programme Jose Soler INFSO/F3, EC TEN-TELECOM Information Day.

Electric Vehicles Industrial Cluster - NPO IKEM Corp. (Business entity of EVIC) Changing the Government Agenda of EU's poorest countries using the power.

Collaboration UMC St Radboud - RISO

Why and how we became a mutual Graham Barnes MyCSP Ltd.

Shareholders Meeting August 22, 2013 CONFIDENTIAL1.

Introduction to EuCARD2 & WP4: Applications of Accelerators AccApplic  EuCARD2  WP4: Applications of Accelerators  The applications  Current workshops.

1 BSR InnoReg Panevezys review of WP4 18 January 2011.

Expression of Interest UNICA Science Parks and Incubator Network.

1 A frank dialogue on the future of HIV treatment All the way from the factory to the patient Sunday 20 th July 2014, 13:30 – 15:30 Presented at the 20.

Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.

The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.

ARDENT MEETING Andrej Sipaj June 13 th, ABOUT ME  Born and raised in Slovakia  Studied: BEng in Mechanical Engineering at UOIT, Canada MASc in.

DUTCH RESEARCH let us inspire your career Presentation for the PhDTalent event, September 21st 2012, Paris Virginie Jazede, ANSES, Maison-Alfort Anièce.

Saxion University of Applied Sciences The Netherlands

1 VSNU Association of Universities in the Netherlands Dutch Universities: innovative education and Internationalization Prof. Dr. M. Paul, Prseident, Maastricht.

LOGO Foundation for Assistance to Small Innovative Enterprises (FASIE) 2014 State Activities to Support Innovations in Russia.

The Value of Partnerships in Fighting HIV/AIDS in Romania: Bringing Children New Hope Jeffrey L. Sturchio Vice President, External Affairs Europe, Middle.

Report from WP4: Applications of Accelerators AccApplic  Accelerator Applications  Aims of WP4  Workshops so far  Future workshops  Status  Plans.

IAEA, Vienna November 2007 SOME PROSPECTS FOR IMPROVING FINANCING OF DEVELOPMENT OF NUCLEAR POWER INFRASTRUCTURE TECHNICAL WORKSHOP ON THE ISSUES FOR THE.

State supporting science and technology challenge. Measures for modern scientific landscape. By Lyudmila Ogorodova Deputy Minister, Ministry of Education.

The external beam radiotherapy and Image-guided radiotherapy (2)

Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.

Possibilities for further intensification of the JINR Educational Programme S.Pakuliak 110 th session of JINR Scientific Council September 15-16, 2011.

Training Our members A partnership initiative to champion sustainability in Abu Dhabi Executive Workshop on Sustainability Reporting The ADSG The Abu Dhabi.

S.Z. Pakuliak Active director of the JINR University Centre 107 th Session of the JINR Scientific Council, February 2010.

SHAAMS Next steps in Lebanon Policy Accelerator Policy Accelerator Activities Activity 1 Participant stakeholders identification Activity 2 Implementation.

FRAC SC Dec 2014 Topic Aspergillus Aspergillus-Update FRAC SC Dec 17, 2014 Meeting in The Hague Situation in the Netherlands Project Rothamsted Research.

Thomas S. Tenforde NCRP President 67 th Meeting of the NEA Committee on Radiation Protection and Public Health Paris, France May 12-14, 2009 Overview of.

September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.

Paul RobbenDutch Health Care Inspectorate Research & Innovation Department Evaluation of supervision and the Academic Collaborative Centre.

87 th International Conference SIEC-ISBE “Education for Business Sustainability” Krakow, July 27-31, 2015 “ Best educational practices from the Arctic.

Collaborative Networks for Conducting Comparative Effectiveness Research Tuesday September 9, :00 – 9:30 am.

SMART FINANCING TECHNIQUES FOR BROWNFIELD REGENERATION BY PUBLIC PRIVATE PARTNERSHIPS Nico Groenendijk Centre for European Studies University of Twente,

Recommendations of the Programme Advisory Committee for Condensed Matter Physics 19 th meeting, November 2003 Wojciech Nawrocik JINR Scientific Council,

Kharkiv international center of nuclear medicine Volodymyr Chizhov, Deputy General Director of NSC KIPT.

Public-Private Partnership Development Platform in Ukraine Non-governmental organization “Public-Private Partnership Development Platform” Київ

“RADIATION ONCOLOGY 101” FOR THE HTM SERVICE PROFESSIONAL

1 Report of PAC for Particle Physics T. Hallman Presented by P. Spillantini JINR Scientific Council Meeting June 3-4, 2004 Dubna, Russia.

Building the Partnership for Sustainable Energy Budapest, September 30 th 2004 REEEP - renewable energy & energy efficiency partnership Dr. Marianne Osterkorn.

| kvi - center for advanced radiation technology 1 KVI-Center for Advanced Radiation Technology M.A. Hofstee 19-sep-2014 RADSAFE Kick-off, CERN.

1 Future Circular Collider Study Preparatory Collaboration Board Meeting September 2014 R-D Heuer Global Future Circular Collider (FCC) Study Goals and.

INFSO-RI Enabling Grids for E-sciencE Plans for the EGEE-2 EGEE 2 Task Force 3rd EGEE Conference, Athens, April 2005.

ENLIGHT,12/2/20021 Health and Science, can CERN contribute? The Mission of CERN (1954): “The Organization shall provide for collaboration among European.

Doing more of the same is not sustainable. Commissioning Journey.

Photoneutron Distributions around 18 MV X-ray Radiotherapy Accelerators using Nuclear Track Detectors Fazal-ur-Rehman, H. Al-Ghamdi, M. I. Al-Jarallah.

The International Plant Protection Convention Presenter organization THE INTERNATIONAL YEAR OF PLANT HEALTH OccasionDate.

” !! Bahrain Development Bank : “ You are not alone ” !!

CERTIFICATION OF MEDICAL PHYSICIST – INDIAN PERSPECTIVE DR. ARUN CHOUGULE ; Ph.D. ASSOCAITE PROF. RADIATION PHYSICS & RSO INCHARGE TELEMEDICINE S.M.S.

Outcomes of the Namibia Water investment Conference Mr Abraham Nehemia Under Secretary for Water Affairs and Forestry 14 September 2012 Ministry of Agriculture,

Creating Start-ups and framing it in the incubator Pim de Bokx Chairman DIA – Dutch Incubation Association Initiator of Pioneerz Partnership.

WP4: Applications of Accelerators AccApplic  WP4: Applications of Accelerators  The applications  Current workshops  Future workshops  Plans EuCARD-2.

Atoms for Health Prof. Dr. Werner Burkart Skolkovo Conference on: Accelerators and Radiation Technologies for the Future of Russia Saint Petersburg,

Often research turns into competitive advantage Do not miss MCDM ! Multiple Criteria Decision Making ( MCDM ) is an intensively growing field of science.

 Nearly 20 years old  Achieved College Status 2013  National ‘go to’ group for cancer nursing and cancer care  Influential  Submissions and lobbying.

HADRONTHERAPY IN ROMANIA NICOLAE IOAN VERGA M.D., Ph.D., D.Sc. “CAROL DAVILA” UNIVERSITY OF MEDICINE AND PHARMACY, ROMANIAN SOCIETY OF HADRONTHERAPY BUCHAREST,

Research and Practical Conference “Accelerators and Radiation technologies for the Futures of Russia” September 2012, Saint-Petersburg Proton Radiation.

Efforts of EGX in Promoting Sustainability in The Capital Market

THE BUSINESS ENTERPRISE LAW CLINIC THE JOHN MARSHALL LAW SCHOOL

Management of Partnerships

Challenges and opportunities for professional acupuncturists in the UK

Press release Release of ISOgray Proton Treatment Planning System

Dr. Chinedu Simeon Aruah MD,MPH, FWACS

A Comparative Study of Biological Effects of VHEE, Protons and other Radiotherapy Modalities Kristina Small University of Manchester, Christie NHS Foundation.

Competitiveness of the regional market, importance of statistics and innovations THE ROLE OF RESEARCH CENTERS IN PROMOTING OF RESEARCH Sarajevo, 8th.

Outreach and Engagement

Sacurima – CA Safety Culture and Risk Management in Agriculture.

Rossana Rivas1, Amelia Villar2, J. Tobey Clark3

Stirling Bryan, PhD Scientific Director, BC SUPPORT Unit

Presentation transcript:

A Symposium on a new development of Proton Radiotherapy Nijmegen, September 17th, 2010 We want to contribute to optimal treatments for patients close to their livings “Stand-alone Proton Units” : a modern technique, innovative and cost effective Jos J. Immerzeel, Radiation Oncologist, RISO

2 Introduction This presentation: Developments in the Netherlands CPAC and the initiative in Deventer Promises and Perils of the new development Aim of this conference Jos J. Immerzeel

3 Developments in the Netherlands 2008: three initiatives in NL: Groningen, UMCG: protoncenter nearby nuclear- physics-accelerator-research center Maastricht: Euregional cooperation (with GER/BE) Amsterdam (NKI)- Rotterdam (Erasmus Univ.)- Leiden (Univ.)- Delft (Techn. Univ): Holland PTC 2009: National Health Counsil: positive (conditional) standpoint 2009: CvZ (College for Health Insurances): report on development of protontherapy; indications 2010: Gouvernmental Decision expected Q4 Jos J. Immerzeel

4 Developments in the Netherlands Potential indications: 7000 # units needed: “Classic” Protoncenter: 3-4 units Is another initiative for proton therapy in East NL necessary? Jos J. Immerzeel “Standard” indications in NL: 250

5 CPAC and the initiative in Deventer 2007: Tomotherapy: DWA development --> CPAC CPAC searches >15 investors/shareholders: RISO? Three investment tranches, three milestones March 2008: Board of RISO informed: positive about the opportunity Juli 2008: Board decision: participate, but no public (RISO) risk-investments possible. Need to search for private investors. Jos J. Immerzeel  2006: new RISO building, also 2 Tomotherapy (IMRT) units; up to now unique in the NL…

6 CPAC and the initiative in Deventer (2) Establishment of DEVPRON BV Second and third tranche: after end of risk period private investment + loan RISO (public ) Milestone 2009: acceleration of protons in a subscale DWA Jos J. Immerzeel First tranche: own investment with funding party. Risk investment (private)

7 CPAC and the initiative in Deventer (3) Participation in DEVPRON BV by the director should be less than 5% Investments by RISO in DWA is only possible when risk towards a succesful development is deminished. After this: the loan of RISO to Devpron BV can be considered as downpayment/investment Once decided to buy a unit, Devpron BV would be taken over by RISO. Jos J. Immerzeel Standpoints of Board of RISO:

8 Investors : first rights to achieve treatment units Participation in CPAC Scientific Advisory Board Installation of Stearing group (Stakeholders) Prof. Jurgen Debus (Heidelberg Ion-beam Therapy centre): Advisor for RISO RISO: search for partners (University!) CPAC and the initiative in Deventer (4) Jos J. Immerzeel 2010: promising developments of DWA

9 Regional cooperation: Technical University Twente and radiotherapy centers National: Investigation for cooperation with other initiatives CPAC and the initiative in Deventer (5) Jos J. Immerzeel July 2010: Partnership with University of Nijmegen/ St. Radboud

10 Promises and Perils of the new development Lower costs regarding infrastructure Lower costs for personell No admixture with neutrons BUT: Dose distribution of Protons: to good! Imaging and dosimetry: extremely important DWA is still a concept….. Jos J. Immerzeel  Installation in existing radiation oncology centers (single vault units)

11 Aim of this conference To inform the audience about the DWA compact Proton Accelerator and the initiative of Deventer /Nijmegen: more than a concept? To convince stakeholders, decision-makers and collegues that this new development really is a chance To initiate cooperation with the other initiatives (UMCG, Holland PTC, Maastricht) Jos J. Immerzeel

12 Cooperation in the Netherlands: Jos J. Immerzeel

13 Programme, Speakers Jos J. Immerzeel IntroductionJ. Immerzeel Clinical experience of particle therapy in Heidelberg M. Münter Technical aspects of protontherapyJ. Schippers DWA developmentsR. Mackie Coffee, Tea Proton facilitiesJ.W. Leer The UMC St.Radboud-RISO collaborationA. Minken PaneldiscussionJ.W. Leer Farewell reception